High levels of AXL expression in untreated EGFR ‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib

For non‐small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations, the initial therapeutic interventions will have crucial impacts on their clinical outcomes. Drug tolerant factors reportedly have an impact on EGFR‐tyrosine kinase inhibitor sensitivity. This pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Akihiro, Yamada, Tadaaki, Serizawa, Masakuni, Uehara, Hisanori, Tanimura, Keiko, Okuma, Yusuke, Fukuda, Akito, Watanabe, Satoshi, Nishioka, Naoya, Takeda, Takayuki, Chihara, Yusuke, Takemoto, Shinnosuke, Harada, Taishi, Hiranuma, Osamu, Shirai, Yukina, Shukuya, Takehito, Nishiyama, Akihiro, Goto, Yasuhiro, Shiotsu, Shinsuke, Kunimasa, Kei, Morimoto, Kenji, Katayama, Yuki, Suda, Kenichi, Mitsudomi, Tetsuya, Yano, Seiji, Kenmotsu, Hirotsugu, Takahashi, Toshiaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899603/
https://www.ncbi.nlm.nih.gov/pubmed/36169649
http://dx.doi.org/10.1111/cas.15608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899603/
https://www.ncbi.nlm.nih.gov/pubmed/36169649
http://dx.doi.org/10.1111/cas.15608

Ejemplares similares